Evolving concepts in cell therapy of liver disease and current clinical perspectives.
The clinical use of cells for the treatment of liver disease is not a mere hypothesis. Indeed, it has been known for more than 30 years that, following intraportal infusion, exogenous hepatocytes isolated from a donor liver engraft into the recipient hepatic parenchyma and express metabolic activity. These experimental results encouraged pilot clinical trials using hepatocytes transplantation to treat a variety of liver diseases. More recently, the discovery of liver stem/progenitor cells further fueled the interest in the field. However, it appears that successful liver cell therapy will require better understanding of the mechanisms governing liver regeneration and of their implication in cell transplantation. This review summarizes some recent advances in the field in a bench-to-bedside perspective.
Muraca
Maurizio
M
Department of Laboratory Medicine, IRCCS Ospedale Bambino Gesù, Rome, Italy. maurizio.muraca@opbg.net
D016026:Bone Marrow Transplantation; D018380:Hematopoietic Stem Cell Transplantation; D022781:Hepatocytes / Q000637:transplantation*; D006801:Humans; D008107:Liver Diseases / Q000601:surgery*; D008115:Liver Regeneration; D045164:Mesenchymal Stem Cell Transplantation; D039902:Multipotent Stem Cells / Q000637:transplantation; D033581:Stem Cell Transplantation